Investor Presentaiton slide image

Investor Presentaiton

Novo Nordisk Annual Report 2023 Product overview¹ DIABETES Introducing Novo Nordisk Strategic Aspirations Risks Management Consolidated statements Additional information 101 OBESITY New-generation insulin and combinations ⚫ TresibaⓇ, insulin degludec ⚫ RyzodegⓇ, insulin degludec/insulin aspart Fiasp®, fast-acting insulin aspart ⚫XultophyⓇ2, insulin degludec/liraglutide Modern insulin • Levemir, insulin detemir NovoRapid, insulin aspart ⚫ NovoMix® 30, biphasic insulin aspart NovoMix® 50, biphasic insulin aspart NovoMix® 70, biphasic insulin aspart4 Human insulin •Insulatard® isophane (NPH) insulin • Actrapid, regular human insulin ⚫ Mixtard® 30, biphasic human insulin ⚫ Mixtard® 40, biphasic human insulin ⚫ Mixtard® 50, biphasic human insulin Glucagon-like peptide-1 Victoza, liraglutide ⚫ OzempicⓇ, semaglutide . RybelsusⓇ, oral semaglutide Pre-filled delivery systems ⚫FlexTouch®, U100, U200 • FlexPenⓇ Durable delivery systems • NovoPen® 6 • NovoPen® 5 • NovoPen® 4 • NovoPen Echo® Plus ⚫ NovoPen Echo® Other delivery systems . PumpCart®, NovoRapidⓇ and FiaspⓇ cartridge to be used in pump • Penfill® cartridge • MallyaⓇ Oral antidiabetic agents • Novo NormⓇ, repaglinide Glucagon • GlucaGen®, glucagon (vial and HypokitⓇ) • Zegalogue, dasiglucagon Needles • NovoFine® Plus ⚫ NovoFine® • NovoTwist® • NovoFineⓇ AutoCover® Glucagon-like peptide-1 • SaxendaⓇ, liraglutide 3.0 mg . WegovyⓇ, semaglutide 2.4 mg Obesity delivery systems Saxenda, FlexTouch® Wegovy Single Dose Device and FlexTouch® . • InnoLetⓇ • Ozempic®, FlexTouch® RARE DISEASE Rare blood disorders ⚫ NovoSevenⓇ, eptacog alfa (recombinant activated factor VII) ⚫ NovoEight®5, turoctocog alfa (recombinant factor VIII) • NovoThirteen®, catridecacog (recombinant factor XIII) ⚫ RefixiaⓇ6, nonacog beta pegol, N9-GP (recombinant factor IX) . Esperoct, turoctocog alfa pegol, N8-GP (recombinant factor VIII) Alhemo®, concizumab (anti-TFPI) Rare endocrine disorders ⚫ NorditropinⓇ, somatropin (rDNA origin) • Sogroya®, somapacitan (rDNA origin) Pre-filled human growth hormone delivery systems • FlexPro® • NordiFlex® Other delivery systems • PenMate®, automatic needle inserter for NordiFlex® • Hormone replacement therapies VagifemⓇ7, estradiol hemihydrate • Activelle®, estradiol/norethisterone acetate ⚫ KliogestⓇ, estradiol/norethisterone acetate ⚫ NovofemⓇ, estradiol/norethisterone acetate • Trisequens®, estradiol/norethisterone acetate • EstrofemⓇ, estradiol 1. Products listed may not be available in all markets. 2. In the US approved under the brand name Xultophy 100/3.6. 3. In the US called Novo Log. 4. The global discontinuation of NovoMix 70 and Mixtard® 40 has been communicated. 5. In the US written Novoeight. 6. In the US approved under the name of REBINYN®. 7. In the UK also called gina®.
View entire presentation